Eversept Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Eversept Partners's RGEN Position: Q1 2026 in Review
Eversept Partners opened a new position in Repligen (RGEN) in Q1 2026: 120,785 shares worth $14.2M. The stake represents 0.75% of the portfolio and ranks #33 among its holdings. This is a return to the name: Eversept Partners previously reported a position in RGEN as recently as Q3 2025.
Eversept Partners first reported a position in RGEN in Q1 2021 and has held it in 20 quarters since. The position peaked at $24.5M in Q2 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Eversept Partners held 120,785 shares of Repligen worth $14.2M as of Q1 2026.
- Repligen was a new Eversept Partners position in Q1 2026.
- Repligen made up 0.75% of Eversept Partners's portfolio in Q1 2026, its #33 holding.
- Eversept Partners first reported a position in Repligen in Q1 2021 and has held it in 20 quarters since.
- Eversept Partners's Repligen position peaked at $24.5M in Q2 2024.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.